86 related articles for article (PubMed ID: 17074954)
1. An inverse relationship between perceived harm and participation willingness in schizophrenia research protocols.
Roberts LW; Hammond KG; Hoop J
Am J Psychiatry; 2006 Nov; 163(11):2002-4. PubMed ID: 17074954
[TBL] [Abstract][Full Text] [Related]
2. Patient and psychiatrist ratings of hypothetical schizophrenia research protocols: assessment of harm potential and factors influencing participation decisions.
Roberts LW; Warner TD; Brody JL; Roberts B; Lauriello J; Lyketsos C
Am J Psychiatry; 2002 Apr; 159(4):573-84. PubMed ID: 11925295
[TBL] [Abstract][Full Text] [Related]
3. Worth the risk? Relationship of incentives to risk and benefit perceptions and willingness to participate in schizophrenia research.
Dunn LB; Kim DS; Fellows IE; Palmer BW
Schizophr Bull; 2009 Jul; 35(4):730-7. PubMed ID: 18281293
[TBL] [Abstract][Full Text] [Related]
4. Influence of ethical safeguards on research participation: comparison of perspectives of people with schizophrenia and psychiatrists.
Roberts LW; Hammond KA; Warner TD; Lewis R
Am J Psychiatry; 2004 Dec; 161(12):2309-11. PubMed ID: 15569905
[TBL] [Abstract][Full Text] [Related]
5. Optimistic bias in the perception of personal risk: patterns in schizophrenia.
Prentice KJ; Gold JM; Carpenter WT
Am J Psychiatry; 2005 Mar; 162(3):507-12. PubMed ID: 15741467
[TBL] [Abstract][Full Text] [Related]
6. Influences upon willingness to participate in schizophrenia research: an analysis of narrative data from 63 people with schizophrenia.
Kaminsky A; Roberts LW; Brody JL
Ethics Behav; 2003; 13(3):279-302. PubMed ID: 14680009
[TBL] [Abstract][Full Text] [Related]
7. Informed consent in medication-free schizophrenia research.
Moser DJ; Reese RL; Schultz SK; Benjamin ML; Arndt S; Fleming FW; Andreasen NC
Am J Psychiatry; 2005 Jun; 162(6):1209-11. PubMed ID: 15930073
[TBL] [Abstract][Full Text] [Related]
8. Assessment of therapeutic misconception in older schizophrenia patients with a brief instrument.
Dunn LB; Palmer BW; Keehan M; Jeste DV; Appelbaum PS
Am J Psychiatry; 2006 Mar; 163(3):500-6. PubMed ID: 16513873
[TBL] [Abstract][Full Text] [Related]
9. Subjective evaluations of research participation by persons with mental illness.
Rosen C; Grossman LS; Sharma RP; Bell CC; Mullner R; Dove HW
J Nerv Ment Dis; 2007 May; 195(5):430-5. PubMed ID: 17502809
[TBL] [Abstract][Full Text] [Related]
10. Healthy individuals' perspectives on clinical research protocols and influences on enrollment decisions.
Roberts LW; Kim JP
AJOB Empir Bioeth; 2017; 8(2):89-98. PubMed ID: 28949845
[TBL] [Abstract][Full Text] [Related]
11. Schizophrenia research participants' responses to protocol safeguards: recruitment, consent, and debriefing.
Roberts LW; Warner TD; Anderson CT; Smithpeter MV; Rogers MK
Schizophr Res; 2004 Apr; 67(2-3):283-91. PubMed ID: 14984889
[TBL] [Abstract][Full Text] [Related]
12. Perspectives of patients with schizophrenia and psychiatrists regarding ethically important aspects of research participation.
Roberts LW; Warner TD; Brody JL
Am J Psychiatry; 2000 Jan; 157(1):67-74. PubMed ID: 10618015
[TBL] [Abstract][Full Text] [Related]
13. Do patients with schizophrenia wish to be involved in decisions about their medical treatment?
Hamann J; Cohen R; Leucht S; Busch R; Kissling W
Am J Psychiatry; 2005 Dec; 162(12):2382-4. PubMed ID: 16330606
[TBL] [Abstract][Full Text] [Related]
14. Capacity to provide informed consent for participation in schizophrenia and HIV research.
Moser DJ; Schultz SK; Arndt S; Benjamin ML; Fleming FW; Brems CS; Paulsen JS; Appelbaum PS; Andreasen NC
Am J Psychiatry; 2002 Jul; 159(7):1201-7. PubMed ID: 12091200
[TBL] [Abstract][Full Text] [Related]
15. The subjective experience of participation in schizophrenia research: a practical and ethical issue.
Taylor PJ; Awenat Y; Gooding P; Johnson J; Pratt D; Wood A; Tarrier N
J Nerv Ment Dis; 2010 May; 198(5):343-8. PubMed ID: 20458196
[TBL] [Abstract][Full Text] [Related]
16. Why do some patients with schizophrenia want to be engaged in medical decision making and others do not?
Hamann J; Mendel R; Reiter S; Cohen R; Bühner M; Schebitz M; Diplich S; Kissling W; Berthele A
J Clin Psychiatry; 2011 Dec; 72(12):1636-43. PubMed ID: 21367353
[TBL] [Abstract][Full Text] [Related]
17. Do psychiatrists understand research-related experiences, attitudes, and motivations of schizophrenia study participants?
Warner TD; Roberts LW; Nguyen K
Compr Psychiatry; 2003; 44(3):227-33. PubMed ID: 12764711
[TBL] [Abstract][Full Text] [Related]
18. Impaired decision-making ability in subjects with Alzheimer's disease and willingness to participate in research.
Kim SY; Cox C; Caine ED
Am J Psychiatry; 2002 May; 159(5):797-802. PubMed ID: 11986134
[TBL] [Abstract][Full Text] [Related]
19. Attitudes of patients with schizophrenia and depression to psychiatric research: a study in seven European countries.
Schäfer I; Burns T; Fleischhacker WW; Galderisi S; Rybakowski JK; Libiger J; Rössler W; Molodynski A; Edlinger M; Piegari G; Hrnčiarova J; Gorna K; Jaeger M; Fett AK; Hissbach J; Naber D
Soc Psychiatry Psychiatr Epidemiol; 2011 Feb; 46(2):159-65. PubMed ID: 20119828
[TBL] [Abstract][Full Text] [Related]
20. Schizophrenia patients' and psychiatrists' perspectives on ethical aspects of symptom re-emergence during psychopharmacological research participation.
Roberts LW; Warner TD; Nguyen KP; Geppert CM; Rogers MK; Roberts BB
Psychopharmacology (Berl); 2003 Dec; 171(1):58-67. PubMed ID: 12756518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
